NEW YORK (GenomeWeb) – OneOme and Rainbow Genomics today announced a deal to provide OneOme's RightMed pharmacogenomic test with Rainbow Genomics' whole-exome sequencing test services to patients in Hong Kong, Japan, and Macau.

The full OneOme RightMed platform will be offered by Rainbow to patients and physicians, the firms added.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.